Fangda Partners has advised WuXi XDC Cayman Inc. WuXi XDC Cayman Inc. (HK stock code: 2268) has completed a primary placement of 22,227,000 new shares at...
WuXi XDC Conducts US$166 Million Share Placement
WuXi XDC Cayman’s Spinn off from WuXi Biologics
Fangda advised WuXi XDC Cayman Inc. on the deal. WuXi XDC Cayman Inc. successfully spun-off from WuXi Biologics (Cayman) Inc. for a separate listing on the Main...
Huaxin Cement Co., Ltd.’s Hong Kong Listing By Way of Introduction
Clifford Chance advised Huaxin Cement Co., Ltd., Fangda and Grandall advised Shenwan Hongyuan Capital (H.K.) Limited. Huaxin Cement Co., Ltd. announced its B to H Share listing...
Chaoju Eye Care Holdings Limited’s HK$1.36 Billion IPO
Fangda and Harneys advised Chaoju Eye Care Holdings Limited on the deal. Chaoju Eye Care Holdings raised HK$1.36 billion ($175.1 million) in net proceeds from its Hong...




























